Work

IMpower132: A phase III clinical program—1L atezolizumab plus platinum-based chemotherapy in chemo-naive advanced non-squamous NSCLC.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps9101

Authors: Howard Jack West, Makoto Nishio, Manuel Cobo Dols, Haruhiro Saito, Michael Howland, Tien Hoang, Takashi Asakawa, Alan Sandler, Mark A. Socinski

Institutions: The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Hospital Clínico Universitario Virgen de la Victoria, Kanagawa Cancer Center, Genentech, Florida Hospital Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2626379619

Cites:

Cited by: 7

Related to: 10